Epirubicin liposome belongs to a kind of anthracycline chemotherapeutic drug, and adriamycin compared to liposome dosage form chemotherapeutic effect is relatively strong, the heart of the side effects are relatively small. 1. Indications: can be used as a first-line systemic chemotherapy drugs, can also be used in the treatment of the disease has progressed Kaposi’s sarcoma patients of second-line chemotherapy drugs. 2. Adverse reactions: the most common adverse reaction is myelosuppression, leukopenia is the most common adverse reaction in patients, anemia and thrombocytopenia can also be seen. 3. Contraindications: prohibited for those who are allergic to the components of this product, prohibited for pregnant women. 4. Precautions: It is forbidden to use equipment with precipitates or other impurities, and caution should be exercised when using the solution of this product, gloves should be worn. If the drug solution comes into contact with the skin or mucous membranes, it should be washed immediately with soapy water. Epirubicin Liposome must be used under the guidance of an experienced physician, and any discomfort must be seen immediately.